August 22, 2025 - 03:43

Recent advancements in technology for below-the-knee prosthetics are set to revolutionize patient care and significantly reduce waiting times within the NHS. New data-driven fitting techniques have demonstrated that these prosthetics can provide comfort levels comparable to those crafted by highly skilled prosthetists.
This breakthrough could lead to a remarkable 50% reduction in waiting lists for patients requiring prosthetic limbs. The technology utilizes sophisticated algorithms and 3D printing methods to create personalized fittings that cater to individual needs. As a result, patients may experience improved mobility and overall quality of life.
The implications of this development are profound, not only for patients but also for healthcare providers. By streamlining the fitting process and enhancing comfort, the NHS can allocate resources more efficiently and enhance patient satisfaction. This innovative approach marks a significant step forward in prosthetic technology, potentially transforming the landscape of rehabilitation and support for amputees.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...